Antimicrobial activity and bioactive profiling of heterocytous cyanobacterial strains using MS/MS-based molecular networking
Language English Country United States Media print-electronic
Document type Journal Article
Grant support
LO1416
Ministerstvo Školství, Mládeže a Tělovýchovy
LM2015055
Ministerstvo Školství, Mládeže a Tělovýchovy
CZ.1.05/2.1.00/19.0392
Ministerstvo Školství, Mládeže a Tělovýchovy
CZ.02.2.69 / 0.0 / 0.0 / 18_070 / 0010493
International Mobility of Researchers - MSCA-IF II (Institute of Microbiology of the CAS, PRI) funded by Operational Programme Research, Development and Education
19-17868Y
Grantová Agentura České Republiky
Cross-Border cooperation Czech-Bavaria -Project No. 41.
Ministerstvo pro Místní Rozvoj České Republiky
PubMed
31385159
DOI
10.1007/s12223-019-00737-9
PII: 10.1007/s12223-019-00737-9
Knihovny.cz E-resources
- MeSH
- Anti-Bacterial Agents chemistry metabolism pharmacology MeSH
- Gram-Positive Bacteria drug effects MeSH
- Microbial Sensitivity Tests MeSH
- Cyanobacteria chemistry metabolism MeSH
- Tandem Mass Spectrometry MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Anti-Bacterial Agents MeSH
The rapid emergence of resistance in pathogenic bacteria together with a steep decline in economic incentives has rendered a new wave in the drug development by the pharmaceutical industry and researchers. Since cyanobacteria are recognized as wide producers of pharmaceutically important compounds, we investigated thirty-four cyanobacterial extracts prepared by solvents of different polarities for their antimicrobial potential. Almost all tested cyanobacterial strains exhibited some degree of antimicrobial bioactivity, with more general effect on fungal strains compared with bacteria. Surprisingly ~50% of cyanobacterial extracts exhibited specific activity against one or few bacterial indicator strains with Gram-positive bacteria being more affected. Extracts of two most promising strains were subjected to activity-guided fractionation and determination of the minimum inhibitory concentration (MIC) against selected bacterial and fungal isolates. Multiple fractions were responsible for their antimicrobial effect with MIC reaching low-micromolar concentrations and in some of them high level of specificity was recorded. Twenty-six bioactive fractions analyzed on LC-HRMS/MS and Global Natural Product Social Molecular Networking (GNPS) online workflow using dereplication resulted in identification of only forty-nine peptide spectrum matches (PSMs) with eleven unique metabolites spectrum matches (MSMs). Interestingly, only three fractions from Nostoc calcicola Lukešová 3/97 and four fractions from Desmonostoc sp. Cc2 showed the presence of unique MSMs suggesting the presence of unknown antimicrobial metabolites among majority of bioactive fractions from both the strains. Our results highlight potential for isolation and discovery of potential antimicrobial bioactive lead molecules from cyanobacterial extracts.
See more in PubMed
Ecotoxicol Environ Saf. 2016 Feb;124:177-185 PubMed
Folia Microbiol (Praha). 2006;51(3):159-82 PubMed
J Nat Prod. 2008 Jun;71(6):1095-8 PubMed
Can J Infect Dis Med Microbiol. 2005 May;16(3):159-60 PubMed
Molecules. 2018 Oct 16;23(10):null PubMed
J Clin Microbiol. 2007 Jul;45(7):2180-2 PubMed
Chembiochem. 2013 Nov 25;14(17):2329-37 PubMed
Med Res Rev. 2016 Jan;36(1):4-31 PubMed
Phytochemistry. 2012 Feb;74:173-7 PubMed
Clin Infect Dis. 2006 Sep 1;43 Suppl 2:S43-8 PubMed
Folia Microbiol (Praha). 2018 Sep;63(5):569-579 PubMed
Nat Commun. 2018 Oct 2;9(1):4035 PubMed
Mar Drugs. 2016 May 17;14(5): PubMed
Front Microbiol. 2017 Apr 25;8:515 PubMed
Nat Chem Biol. 2017 Jan;13(1):30-37 PubMed
Trends Pharmacol Sci. 2017 Feb;38(2):143-154 PubMed
Environ Toxicol. 2011 Aug;26(4):345-58 PubMed
Nat Microbiol. 2018 Mar;3(3):319-327 PubMed
Microb Biotechnol. 2014 May;7(3):209-20 PubMed
Nat Rev Drug Discov. 2015 Feb;14(2):111-29 PubMed
Crit Rev Microbiol. 2016 May;42(3):394-405 PubMed
Appl Environ Microbiol. 2019 Feb 6;85(4): PubMed
Sci Prog. 2015;98(Pt 2):145-68 PubMed
J Proteome Res. 2008 Jan;7(1):113-22 PubMed
Curr Opin Biotechnol. 2010 Dec;21(6):787-93 PubMed
Nat Biotechnol. 2016 Aug 9;34(8):828-837 PubMed
BMC Evol Biol. 2011 Feb 14;11:45 PubMed
Front Microbiol. 2016 Apr 05;7:416 PubMed
Mar Drugs. 2017 Feb 23;15(3):null PubMed
Proc Natl Acad Sci U S A. 2011 May 24;108(21):8815-20 PubMed
Toxicon. 2018 Aug;150:66-73 PubMed
Rev Iberoam Micol. 2012 Jan-Mar;29(1):29-33 PubMed
Chem Biol. 2012 Jan 27;19(1):85-98 PubMed
Phytochem Anal. 2014 Jan-Feb;25(1):13-28 PubMed
BMC Complement Altern Med. 2017 Feb 7;17(1):99 PubMed
Bioinformatics. 2008 Nov 1;24(21):2534-6 PubMed
Special issue dedicated to the memory of Ivan Šetlík